Literature DB >> 12568824

Achieving utility with family history: colorectal cancer risk.

Deborah J Bowen1, Evette Ludman, Nancy Press, Thuy Vu, Wylie Burke.   

Abstract

Family history of chronic disease is rapidly becoming a research tool for targeting participants at increased risk. Its current usefulness in clinical practice remains unknown. This paper details the possible utility and complications in using family history in a primary care setting, using colorectal cancer risk as the health issue. Where available, we cite data to support the issues that could arise. Where there are no studies, we invite further research. The potential of family history as a health improvement tool is still under review.

Entities:  

Mesh:

Year:  2003        PMID: 12568824     DOI: 10.1016/s0749-3797(02)00591-3

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  4 in total

1.  Perceived risk for cancer in an urban sexual minority.

Authors:  Jack E Burkhalter; Jennifer L Hay; Elliot Coups; Barbara Warren; Yuelin Li; Jamie S Ostroff
Journal:  J Behav Med       Date:  2010-09-25

2.  Coherence and completeness of population-based family cancer reports.

Authors:  Louise Wideroff; Anne O Garceau; Mark H Greene; Marsha Dunn; Timothy McNeel; Phuong Mai; Gordon Willis; Lou Gonsalves; Michael Martin; Barry I Graubard
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-02-16       Impact factor: 4.254

3.  Interest in genetic testing among affected men from hereditary prostate cancer families and their unaffected male relatives.

Authors:  Julie N Harris; Deborah J Bowen; Alan Kuniyuki; Laura McIntosh; Liesel M FitzGerald; Elaine A Ostrander; Janet L Stanford
Journal:  Genet Med       Date:  2009-05       Impact factor: 8.822

4.  Developing Family Healthware, a family history screening tool to prevent common chronic diseases.

Authors:  Paula W Yoon; Maren T Scheuner; Cynthia Jorgensen; Muin J Khoury
Journal:  Prev Chronic Dis       Date:  2008-12-15       Impact factor: 2.830

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.